NCT06310980 (SMARTPEN) is a NA clinical trial of smartpen in Diabetes Mellitus, Type 1, sponsored by Giulio Frontino.

Who is sponsoring NCT06310980?

NCT06310980 is sponsored by Giulio Frontino.

What drugs are being tested in NCT06310980?

Interventions in NCT06310980: smartpen.

What condition does NCT06310980 study?

NCT06310980 studies Diabetes Mellitus, Type 1.

Is NCT06310980 still recruiting?

NCT06310980 is currently status unknown. Last updated 15 March 2024.

Last reviewed 2024-03-15 · How we verify

NCT06310980: SMARTPEN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Study to Verify Effect of Smartpen Coordinated With Glucose Sensor.

Status unknown NA Last updated 15 March 2024

What this trial tests

NA trial testing smartpen in Diabetes Mellitus, Type 1 in 34 participants. Status unknown.

Timeline

1 April 2024

Primary endpoint
1 July 2024

1 April 2025

Quick facts

Lead sponsor	Giulio Frontino
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	34
Start date	1 April 2024
Primary completion	1 July 2024
Estimated completion	1 April 2025

Drugs / interventions tested

smartpen

Conditions studied

Diabetes Mellitus, Type 1 — all drugs for Diabetes Mellitus, Type 1 →

Sponsor

Giulio Frontino

Who can join

Adults 12 to 18, any sex, with Diabetes Mellitus, Type 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Aim of this interventional study in to assess the effect of the use of a smartpen connected by an APP to continuous glucose sensors in a cohort of diabetic adolescents in not good metabolic control. Primary endpoint: time in range Secondary endpoints: other glucometrics, Hba1c, treatment satisfaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

NCT07325461 — Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes · NA · recruiting
NCT07305805 — A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes · Phase 1 · recruiting
NCT06282055 — Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes · recruiting
NCT06325202 — Closed Loop and Education for Hypoglycemia Awareness Restoration · NA · recruiting
NCT07160816 — A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar · recruiting

Other Giulio Frontino trials

Trials by the same sponsor.

NCT06305377 — Achieving Rapid, Safe and Sustained Glucose Control in Adolescents With Suboptimally Controlled Type 1 Diabetes Using Ad · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06310980 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Giulio Frontino
Last refreshed: 15 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06310980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing